International study for treatment of childhood relapsed ALL 2010 with standard therapy, systematic integration of new agents, and establishment of standardised diagnostic and research
IntReALL 2010 is embedded in a network of European academic structures relevant for childhood cancer. It will be a cornerstone of drug development in childhood leukaemia and the only trial with the potential for well-powered phase III studies in this indication. IntReALL 2010 will harmonise ALL-relapse therapy, establish highest diagnostic and therapeutic standard and improve survival of children with ALL.
The CCRI is a partner in this project and Assoc. Prof. Georg Mann, MD, and Assoc. Prof. Andishe Attarbaschi, MD, are the scientists in charge.